Package 51991-292-01

{"route": ["ORAL"], "spl_id": "7b71db65-df59-4739-9e8f-77aea32f80b3", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["682a1210-b26e-426e-8ffe-d25d91bdd608"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (51991-292-01)", "package_ndc": "51991-292-01", "marketing_start_date": "20080111"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (51991-292-05)", "package_ndc": "51991-292-05", "marketing_start_date": "20080111"}], "brand_name": "OXCARBAZEPINE", "product_id": "51991-292_7b71db65-df59-4739-9e8f-77aea32f80b3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51991-292", "generic_name": "OXCARBAZEPINE", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA078069", "marketing_category": "ANDA", "marketing_start_date": "20080111", "listing_expiration_date": "20261231"}